Page last updated: 2024-09-02

triptolide and Non-alcoholic Fatty Liver Disease

triptolide has been researched along with Non-alcoholic Fatty Liver Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Fu, P; Guo, F; Huang, R; Li, G; Li, Y; Liang, Y; Ma, L1

Other Studies

1 other study(ies) available for triptolide and Non-alcoholic Fatty Liver Disease

ArticleYear
Activation of AMPK by triptolide alleviates nonalcoholic fatty liver disease by improving hepatic lipid metabolism, inflammation and fibrosis.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2021, Volume: 92

    Topics: AMP-Activated Protein Kinases; Animals; Diterpenes; Epoxy Compounds; Inflammation; Lipid Metabolism; Lipids; Liver; Liver Cirrhosis; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Non-alcoholic Fatty Liver Disease; Phenanthrenes

2021